Reference
Xia G, et al. EP14.01-001 SCLC Transformation from ALK-rearranged Lung Adenocarcinoma after Alectinib Resistance and Response to Atezolizumab: Case Report. Journal of Thoracic Oncology 17 (Suppl.): S526-S527, No. 9, Sep 2022. Available from: URL: http://doi.org/10.1016/j.jtho.2022.07.938 [abstract]
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1926, 23 (2022). https://doi.org/10.1007/s40278-022-24301-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-24301-4